567 related articles for article (PubMed ID: 18031501)
21. Effects of calcipotriol on stratum corneum barrier function, hydration and cell renewal in humans.
Effendy I; Kwangsukstith C; Chiappe M; Maibach HI
Br J Dermatol; 1996 Oct; 135(4):545-9. PubMed ID: 8915143
[TBL] [Abstract][Full Text] [Related]
22. Effect of an antioxidant (quercetin) on sodium-lauryl-sulfate-induced skin irritation.
Katsarou A; Davoy E; Xenos K; Armenaka M; Theoharides TC
Contact Dermatitis; 2000 Feb; 42(2):85-9. PubMed ID: 10703630
[TBL] [Abstract][Full Text] [Related]
23. Effects of topical corticosteroid and tacrolimus on ceramides and irritancy to sodium lauryl sulphate in healthy skin.
Jungersted JM; Høgh JK; Hellegren LI; Jemec GB; Agner T
Acta Derm Venereol; 2011 May; 91(3):290-4. PubMed ID: 21365172
[TBL] [Abstract][Full Text] [Related]
24. Effects of disinfectants and detergents on skin irritation.
Slotosch CM; Kampf G; Löffler H
Contact Dermatitis; 2007 Oct; 57(4):235-41. PubMed ID: 17868216
[TBL] [Abstract][Full Text] [Related]
25. Additive impairment of the barrier function by mechanical irritation, occlusion and sodium lauryl sulphate in vivo.
Fluhr JW; Akengin A; Bornkessel A; Fuchs S; Praessler J; Norgauer J; Grieshaber R; Kleesz P; Elsner P
Br J Dermatol; 2005 Jul; 153(1):125-31. PubMed ID: 16029337
[TBL] [Abstract][Full Text] [Related]
26. Effects of glycerol on human skin damaged by acute sodium lauryl sulphate treatment.
Atrux-Tallau N; Romagny C; Padois K; Denis A; Haftek M; Falson F; Pirot F; Maibach HI
Arch Dermatol Res; 2010 Aug; 302(6):435-41. PubMed ID: 20043170
[TBL] [Abstract][Full Text] [Related]
27. Long-term management of facial atopic eczema with pimecrolimus cream 1% in paediatric patients with mild to moderate disease.
Zuberbier T; Bräutigam M
J Eur Acad Dermatol Venereol; 2008 Jun; 22(6):718-21. PubMed ID: 18312323
[TBL] [Abstract][Full Text] [Related]
28. Different effects of pimecrolimus and betamethasone on the skin barrier in patients with atopic dermatitis.
Jensen JM; Pfeiffer S; Witt M; Bräutigam M; Neumann C; Weichenthal M; Schwarz T; Fölster-Holst R; Proksch E
J Allergy Clin Immunol; 2009 May; 123(5):1124-33. PubMed ID: 19410693
[TBL] [Abstract][Full Text] [Related]
29. Increased permeability for polyethylene glycols through skin compromised by sodium lauryl sulphate.
Jakasa I; Verberk MM; Bunge AL; Kruse J; Kezic S
Exp Dermatol; 2006 Oct; 15(10):801-7. PubMed ID: 16984262
[TBL] [Abstract][Full Text] [Related]
30. Results of a randomized, double-blind, vehicle-controlled efficacy trial of pimecrolimus cream 1% for the treatment of moderate to severe facial seborrheic dermatitis.
Warshaw EM; Wohlhuter RJ; Liu A; Zeller SA; Wenner RA; Bowers S; Schultz JC; Katz HI; McCormick CL; Parneix-Spake A
J Am Acad Dermatol; 2007 Aug; 57(2):257-64. PubMed ID: 17188780
[TBL] [Abstract][Full Text] [Related]
31. Effect of topically applied lipids on surfactant-irritated skin.
Lodén M; Andersson AC
Br J Dermatol; 1996 Feb; 134(2):215-20. PubMed ID: 8746332
[TBL] [Abstract][Full Text] [Related]
32. A randomized controlled trial of pimecrolimus cream 1% in adolescents and adults with head and neck atopic dermatitis and intolerant of, or dependent on, topical corticosteroids.
Murrell DF; Calvieri S; Ortonne JP; Ho VC; Weise-Riccardi S; Barbier N; Paul CF
Br J Dermatol; 2007 Nov; 157(5):954-9. PubMed ID: 17935515
[TBL] [Abstract][Full Text] [Related]
33. The safety and efficacy of pimecrolimus, 1%, cream for the treatment of Netherton syndrome: results from an exploratory study.
Yan AC; Honig PJ; Ming ME; Weber J; Shah KN
Arch Dermatol; 2010 Jan; 146(1):57-62. PubMed ID: 20083693
[TBL] [Abstract][Full Text] [Related]
34. Metallothionein I and II gene knock-out mice exhibit reduced tolerance to 24-h sodium lauryl sulphate patch testing.
Ma C; Li LF; Zhang BX
Clin Exp Dermatol; 2007 Jul; 32(4):417-22. PubMed ID: 17362230
[TBL] [Abstract][Full Text] [Related]
35. Skin reaction and recovery: a repeated sodium lauryl sulphate patch test vs. a 24-h patch test and tape stripping.
Koopman DG; Kezić S; Verberk MM
Br J Dermatol; 2004 Mar; 150(3):493-9. PubMed ID: 15030332
[TBL] [Abstract][Full Text] [Related]
36. Topical pimecrolimus in the treatment of genital lichen planus: a prospective case series.
Lonsdale-Eccles AA; Velangi S
Br J Dermatol; 2005 Aug; 153(2):390-4. PubMed ID: 16086755
[TBL] [Abstract][Full Text] [Related]
37. A randomized, double-blind, vehicle-controlled study of 1% pimecrolimus cream in adult patients with perioral dermatitis.
Schwarz T; Kreiselmaier I; Bieber T; Thaci D; Simon JC; Meurer M; Werfel T; Zuberbier T; Luger TA; Wollenberg A; Bräutigam M
J Am Acad Dermatol; 2008 Jul; 59(1):34-40. PubMed ID: 18462835
[TBL] [Abstract][Full Text] [Related]
38. Pimecrolimus cream 1% in the long-term management of adult atopic dermatitis: prevention of flare progression. A randomized controlled trial.
Gollnick H; Kaufmann R; Stough D; Heikkila H; Andriano K; Grinienko A; Jimenez P;
Br J Dermatol; 2008 May; 158(5):1083-93. PubMed ID: 18341665
[TBL] [Abstract][Full Text] [Related]
39. Safety and tolerability of 1% pimecrolimus cream among infants: experience with 1133 patients treated for up to 2 years.
Paul C; Cork M; Rossi AB; Papp KA; Barbier N; de Prost Y
Pediatrics; 2006 Jan; 117(1):e118-28. PubMed ID: 16361223
[TBL] [Abstract][Full Text] [Related]
40. Pimecrolimus 1% cream in the treatment of facial psoriasis: a 16-week open-label study.
Jacobi A; Braeutigam M; Mahler V; Schultz E; Hertl M
Dermatology; 2008; 216(2):133-6. PubMed ID: 18216475
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
